Literature DB >> 15050870

Brain serotonin 1A receptor binding in bulimia nervosa.

Jari Tiihonen1, Anna Keski-Rahkonen, Mari Löppönen, Maria Muhonen, Jaana Kajander, Topias Allonen, Kjell Någren, Jarmo Hietala, Aila Rissanen.   

Abstract

BACKGROUND: Selective serotonin reuptake inhibitors (SSRIs) are the first choice for the pharmacologic treatment of bulimia nervosa, but there are no published data on the putative altered serotonin (5-HT) receptor characteristics in patients with bulimia. Experimental studies suggest that the therapeutic antidepressant effect of SSRIs is mediated via 5-HT(1A) receptors. The aim of this study was to measure brain 5-HT(1A) receptor binding among nonmedicated patients with bulimia nervosa.
METHODS: Positron emission tomography (PET) with a selective 5-HT(1A) ligand, [11C]WAY-100635, was performed on eight unmedicated patients with bulimia and 10 healthy comparison subjects.
RESULTS: The binding potential values were greater in patients than in control subjects in all brain regions studied. The most robust differences were observed in the angular gyrus, the medial prefrontal cortex, and the posterior cingulate cortex.
CONCLUSIONS: These results suggest that brain 5-HT(1A) receptor binding is increased in several cortical areas in patients with bulimia nervosa during their state of impulsive binge eating.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15050870     DOI: 10.1016/j.biopsych.2003.12.016

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN: 0006-3223            Impact factor:   13.382


  16 in total

1.  Associations between the serotonin-1A receptor C(-1019)G polymorphism and disordered eating symptoms in female adolescents.

Authors:  Se-Won Lim; Juwon Ha; Dong-Won Shin; Hee-Yeon Woo; Kye-Hyun Kim
Journal:  J Neural Transm (Vienna)       Date:  2010-05-09       Impact factor: 3.575

Review 2.  PET tracers for serotonin receptors and their applications.

Authors:  J S Dileep Kumar; J John Mann
Journal:  Cent Nerv Syst Agents Med Chem       Date:  2014

3.  5-HT₁A receptor binding is increased after recovery from bulimia nervosa compared to control women and is associated with behavioral inhibition in both groups.

Authors:  Ursula F Bailer; Cinnamon S Bloss; Guido K Frank; Julie C Price; Carolyn C Meltzer; Chester A Mathis; Mark A Geyer; Angela Wagner; Carl R Becker; Nicholas J Schork; Walter H Kaye
Journal:  Int J Eat Disord       Date:  2010-09-24       Impact factor: 4.861

Review 4.  Current status of functional imaging in eating disorders.

Authors:  Guido K W Frank; Walter H Kaye
Journal:  Int J Eat Disord       Date:  2012-04-25       Impact factor: 4.861

5.  Human Freud-2/CC2D1B: a novel repressor of postsynaptic serotonin-1A receptor expression.

Authors:  Mahmoud R Hadjighassem; Mark C Austin; Bernadeta Szewczyk; Mireille Daigle; Craig A Stockmeier; Paul R Albert
Journal:  Biol Psychiatry       Date:  2009-05-07       Impact factor: 13.382

Review 6.  Advances from neuroimaging studies in eating disorders.

Authors:  Guido K W Frank
Journal:  CNS Spectr       Date:  2015-04-23       Impact factor: 3.790

7.  Altered temporal difference learning in bulimia nervosa.

Authors:  Guido K W Frank; Jeremy R Reynolds; Megan E Shott; Randall C O'Reilly
Journal:  Biol Psychiatry       Date:  2011-06-29       Impact factor: 13.382

Review 8.  Neurobiology of anorexia and bulimia nervosa.

Authors:  Walter Kaye
Journal:  Physiol Behav       Date:  2007-11-29

9.  Serotonin-induced decrease of intracellular Ca(2+) release in platelets of bulimic patients normalizes during treatment.

Authors:  Lars Wöckel; Florian Daniel Zepf; Sabrina Koch; Anikó-Eva Meyer-Keitel; Martin H Schmidt
Journal:  J Neural Transm (Vienna)       Date:  2008-12-10       Impact factor: 3.575

10.  Deficient activity in the neural systems that mediate self-regulatory control in bulimia nervosa.

Authors:  Rachel Marsh; Joanna E Steinglass; Andrew J Gerber; Kara Graziano O'Leary; Zhishun Wang; David Murphy; B Timothy Walsh; Bradley S Peterson
Journal:  Arch Gen Psychiatry       Date:  2009-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.